L. Rinaman et al., DISTRIBUTION AND NEUROCHEMICAL PHENOTYPES OF CAUDAL MEDULLARY NEURONSACTIVATED TO EXPRESS CFOS FOLLOWING PERIPHERAL ADMINISTRATION OF CHOLECYSTOKININ, Journal of comparative neurology, 338(4), 1993, pp. 475-490
Immunocytochemical localization of the protein product of the proto-on
cogene c-fos allows anatomical identification of physiologically activ
ated neurons. The present study examined the subnuclear distribution o
f cFos protein in the rat caudal medulla following peripheral administ
ration of cholecystokinin octapeptide, which reduces feeding and gastr
ic motility by a vagally mediated mechanism. To begin phenotypic chara
cterization of neurons activated to express cFos following cholecystok
inin treatment, double-labeling techniques were used to identify vagal
motor neurons and neurons immunoreactive for tyrosine hydroxylase, ne
uropeptide Y, and neurotensin. Activated cells were most prevalent in
the subnucleus medialis of the nucleus of the solitary tract, less pre
valent in the subnucleus commissuralis, and virtually absent in the su
bnuclei centralis and gelatinosus. Many activated cells occupied the c
audal area postrema; some of these were catecholaminergic. In contrast
, activated cells were sparse within the medial rostral area postrema.
Other activated cells occupied the dorso- and ventrolateral medulla a
nd the midline raphe nuclei. Retrograde labeling of vagal motor neuron
s confirmed that very few were activated. Those that were activated oc
cupied the caudal dorsal motor nucleus. In the dorsomedial medulla, 51
% of catecholaminergic neurons and 39% of neurons positive for neurope
ptide Y were activated, but no neurotensin-positive neurons were activ
ated. In the ventrolateral medulla, 25% of catecholaminergic neurons a
nd 27% of neuropeptide Y-positive neurons were activated. By character
izing the subnuclear distribution and chemical phenotypes of neurons a
ctivated by exogenous cholecystokinin, these data contribute to elucid
ation of the neural circuits mediating the behavioral, physiological,
and neuroendocrine effects produced by this peptide. (C) 1993 Wiley-Li
ss, Inc.